Last updated: 24 May 2023 at 6:27pm EST

Raymond Kubacki Net Worth




The estimated Net Worth of Raymond C Jr Kubacki is at least $1.22 Million dollars as of 8 December 2020. Mr. Kubacki owns over 1,000 units of Psychemedics stock worth over $487,701 and over the last 21 years he sold PMD stock worth over $0. In addition, he makes $736,800 as Chairman of the Board, President und Chief Executive Officer at Psychemedics.

Mr. Kubacki PMD stock SEC Form 4 insiders trading

Raymond has made over 15 trades of the Psychemedics stock since 2003, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of PMD stock worth $5,000 on 8 December 2020.

The largest trade he's ever made was exercising 77,300 units of Psychemedics stock on 22 May 2015 worth over $1,113,120. On average, Raymond trades about 2,853 units every 97 days since 2003. As of 8 December 2020 he still owns at least 214,374 units of Psychemedics stock.

You can see the complete history of Mr. Kubacki stock trades at the bottom of the page.





Raymond Kubacki biography

Raymond C. Kubacki Jr. serves as Chairman of the Board, President, Chief Executive Officer of the Company. He has been the Company’s President and Chief Executive Officer since 1991. He has also served as Chairman of the Board of the Company since 2003. From 2011 until 2016, he served as a director of Integrated Environmental Technologies, Ltd. From 2007 until 2010, he served as a director of Protection One, Inc. and from 2004 to 2007 he served as a director of Integrated Alarm Services Group, Inc. He is also a trustee of the Center for Excellence in Education based in Washington, D.C. and holds an Executive Masters Professional Director Certification from the American College of Corporate Directors, an organization that provides educational and other services to public company directors, chief executive officers and corporate counsel. As a result of these and other professional experiences, Mr. Kubacki possesses particular knowledge and experience in marketing and operations that strengthen the Board’s collective qualifications, skills and experience. Mr. Kubacki has been a director of the Company since 1991.

What is the salary of Raymond Kubacki?

As the Chairman of the Board, President und Chief Executive Officer of Psychemedics, the total compensation of Raymond Kubacki at Psychemedics is $736,800. There are no executives at Psychemedics getting paid more.



How old is Raymond Kubacki?

Raymond Kubacki is 75, he's been the Chairman of the Board, President und Chief Executive Officer of Psychemedics since 2003. There are 4 older and 5 younger executives at Psychemedics. The oldest executive at Psychemedics Corp. is Harry Connick, 94, who is the Independent Director.

What's Raymond Kubacki's mailing address?

Raymond's mailing address filed with the SEC is C/O PSYCHEMEDICS CORPORATION, 289 GREAT ROAD, SUITE 200, ACTON, MA, 01720.

Insiders trading at Psychemedics

Over the last 21 years, insiders at Psychemedics have traded over $2,633,903 worth of Psychemedics stock and bought 95,845 units worth $742,060 . The most active insiders traders include Peter Kamin, A Clinton Allen und Raymond C Jr Kubacki. On average, Psychemedics executives and independent directors trade stock every 101 days with the average trade being worth of $18,935. The most recent stock trade was executed by Charles M Doucot on 17 August 2023, trading 12,700 units of PMD stock currently worth $59,182.



What does Psychemedics do?

psychemedics (nasdaq: pmd) is the world's leading drug testing company using hair for the detection of drugs of abuse. psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on psychemedics’ patented hair analysis technology for their pre-employment and employee drug screening. psychemedics'​ clients include over 10% of the fortune 500, some of the largest police departments in america, federal reserve banks, and schools. for more information, visit the psychemedics website at www.psychemedics.com.



What does Psychemedics's logo look like?

Psychemedics Corp. logo

Complete history of Mr. Kubacki stock trades at Psychemedics

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
8 Dec 2020 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Kauf 1,000 $5.00 $5,000
8 Dec 2020
214,374
12 Nov 2020 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Kauf 2,000 $3.86 $7,720
12 Nov 2020
213,374
14 Jun 2019 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Kauf 1,000 $9.99 $9,990
14 Jun 2019
176,374
14 Nov 2017 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Kauf 1,000 $16.88 $16,880
14 Nov 2017
178,228
10 Sep 2015 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Kauf 2,000 $10.12 $20,240
10 Sep 2015
185,647
10 Sep 2015 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Kauf 2,000 $10.12 $20,240
10 Sep 2015
185,647
22 May 2015 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Optionausübung 77,300 $14.40 $1,113,120
22 May 2015
264,776
13 Feb 2014 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Optionausübung 10,000 $11.85 $118,500
13 Feb 2014
173,346
6 Mar 2009 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Kauf 1,000 $4.27 $4,270
6 Mar 2009
101,644
4 Apr 2005 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Optionausübung 10,300 $11.28 $116,184
4 Apr 2005
74,821
1 Apr 2005 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Optionausübung 1,600 $11.28 $18,048
1 Apr 2005
66,121
29 Mar 2005 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Optionausübung 18,700 $11.28 $210,936
29 Mar 2005
83,221
22 Mar 2005 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Optionausübung 8,025 $11.28 $90,522
22 Mar 2005
72,546
22 Mar 2005 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Optionausübung 8,025 $11.28 $90,522
22 Mar 2005
72,546
3 Dec 2003 Raymond C Jr Kubacki
Vorsitzende, CEO und Präsident
Optionausübung 38,626 $7.40 $285,832
3 Dec 2003
100,637


Psychemedics executives and stock owners

Psychemedics executives and other stock owners filed with the SEC include: